📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors. (2020)

First Author: Wanigasooriya K
Attributed to:  Integrating innovative technologies for genotyping and phenotyping in stratified medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers12051278

PubMed Identifier: 32443649

Publication URI: http://europepmc.org/abstract/MED/32443649

Type: Journal Article/Review

Volume: 12

Parent Publication: Cancers

Issue: 5

ISSN: 2072-6694